Skip Navigation

This Article
Right arrow Print PDF (4075K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (74)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Pritchard, C. E.
Right arrow Articles by Gait, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pritchard, C. E.
Right arrow Articles by Gait, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1994, Vol. 22, No. 13 2592-2600
© 1994


RNA

Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins

Clare E. Pritchard+, Jane A. Grasby, François Hamy§, Anthony M. Zacharek, Mohinder Singh, Jonathan Karn and Michael J. Gait*

MRC Laboratory of Molecular Biology Hills Road, Cambridge CB2 2QH, UK Department of Biochemical Sciences, Harvard University Cambridge, MA, USA

*To whom correspondence should be addressed

Received March 22, 1994. Revised May 25, 1994. Accepted May 25, 1994.

The HIV-1 regulatory proteins tat and rev are both RNA binding proteins which recognize sequences in duplex RNA which are close to structural distortions. Here we identify phosphate contacts which are critical for each binding reaction by use of a new method. Model RNA binding sites are constructed carrying substitutions of individual phosphodiesters by uncharged methylphosphonate derivatives isolated separately as ftp and Sp diastereoisomers and tested for protein binding by competition assays. In the binding of tat to the trans-activation response region (TAR), three phosphates, P21 and P22 which are adjacent to the U-rich bulge and P40 on the opposite strand, are essential and in each case both isomers inhibit binding. Similarly, in the interaction between the HIV-1 rev protein and the revresponsive element (RRE) both methylphosphonate isomers at P103, P104, P124 and P125 interfere with rev binding. At P106, only the Rp methylphosphonate isomer is impaired in rev binding ability and it is proposed that the Rp oxygen is hydrogen-bonded to an uncharged amino acid or to a main chain hydrogen atom. Synthetic chemistry techniques also provide evidence for the conformations of non-Watson - Crick G106:G129 and G105:A131 base-pairs in the RRE ‘bubble’ structure upon rev binding. Almost all functional groups on the 5 bulged residues in the bubble have been ruled out as sites of contact with rev but, by contrast, the N7-positions of each G residue in the flanking base-pairs are identified as sites of likely hydrogen-bonding to rev. The results show that both tat and rev recognize the major groove of distorted RNA helixes and that both proteins make specific contacts with phosphates which are displaced from the sites of base-pair contact.


+Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK

§Ciba-Geigy AG, CH-4002 Basel, Switzerland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. An, G. Barany, and K. Musier-Forsyth
Evolution of acceptor stem tRNA recognition by class II prolyl-tRNA synthetase
Nucleic Acids Res., May 1, 2008; 36(8): 2514 - 2521.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
F. Hamy, E. Felder, K. Lipson, and T. Klimkait
Merged Screening for Human Immunodeficiency Virus Tat and Rev Inhibitors
J Biomol Screen, June 1, 2001; 6(3): 179 - 187.
[Abstract] [PDF]


Home page
Nucleic Acids ResHome page
R. Nifosi, C. M. Reyes, and P. A. Kollman
Molecular dynamics studies of the HIV-1 TAR and its complex with argininamide
Nucleic Acids Res., December 15, 2000; 28(24): 4944 - 4955.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Ippolito and T. A. Steitz
A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation
PNAS, August 18, 1998; 95(17): 9819 - 9824.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. E. Johansson, D. Dertinger, K. A. LeCuyer, L. S. Behlen, C. H. Greef, and O. C. Uhlenbeck
A thermodynamic analysis of the sequence-specific binding of RNA by bacteriophage MS2 coat protein
PNAS, August 4, 1998; 95(16): 9244 - 9249.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Hamy, E. R. Felder, G. Heizmann, J. Lazdins, F. Aboul-ela, G. Varani, J. Karn, and T. Klimkait
An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
PNAS, April 15, 1997; 94(8): 3548 - 3553.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. L. Battiste, H. Mao, N. S. Rao, R. Tan, D. R. Muhandiram, L. E. Kay, A. D. Frankel, and J. R. Williamson
alpha Helix-RNA Major Groove Recognition in an HIV-1 Rev Peptide-RRE RNA Complex
Science, September 13, 1996; 273(5281): 1547 - 1551.
[Abstract]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.